Relationship between maternal immunological response during pregnancy and onset of preeclampsia

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Martínez Varea, Alicia ^a   Pellicer, Begoña ^b   Perales Marín, Alfredo ^a   Pellicer, Antonio ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B7 PROTEIN; COMPLEMENT; FAS LIGAND; FETAL ANTIGEN; HLA ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; MATERNAL ANTIBODY; MEMBRANE PROTEIN; RANTES; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL FUNCTION; CELL INVASION; CLINICAL IMMUNOLOGY; COMPLEMENT SYSTEM; DECIDUALIZATION; DENDRITIC CELL; DISEASE ASSOCIATION; ENDOMETRIUM; FERTILIZATION IN VITRO; FETUS OUTCOME; HLA SYSTEM; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE FUNCTION; MACROPHAGE; NATURAL KILLER CELL; OOCYTE DONATION; PREECLAMPSIA; PREGNANCY; PREVALENCE; PROTEIN FAMILY; REGULATORY T LYMPHOCYTE; REVIEW; SEMEN ANALYSIS; SYNCYTIOTROPHOBLAST; TROPHOBLAST; FEMALE; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; PRE-ECLAMPSIA;

FEMALE; HUMANS; IMMUNE TOLERANCE; MATERNAL-FETAL EXCHANGE; OOCYTE DONATION; PRE-ECLAMPSIA; PREGNANCY;

EID: 84903649835     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/210241     Document Type: Review

References (114)

1. Aagaard-Tillery K. M., Silver R., Dalton J., Immunology of normal pregnancy. Seminars in Fetal and Neonatal Medicine 2006 11 5 279 295 2-s2.0-33745957380 10.1016/j.siny.2006.04.003 (Pubitemid 44056291)
2. Steegers E. A. P., von Dadelszen P., Duvekot J. J., Pijnenborg R., Pre-eclampsia. The Lancet 2010 376 9741 631 644 2-s2.0-77956061313 10.1016/S0140-6736(10)60279-6
3. Heikkilä A., Tuomisto T., Häkkinen S.-K., Keski-Nisula L., Heinonen S., Ylä-Herttuala S., Tumor suppressor and growth regulatory genes are overexpressed in severe early-onset preeclampsia-an array study on case-specific human preeclamptic placental tissue. Acta Obstetricia et Gynecologica Scandinavica 2005 84 7 679 689 2-s2.0-21444444736 10.1111/j.0001-6349.2005.00814.x (Pubitemid 40917393)
4. van der Hoorn M. L. P., Lashley E. E. L. O., Bianchi D. W., Claas F. H. J., Schonkeren C. M. C., Scherjon S. A., Clinical and immunologic aspects of egg donation pregnancies: a systematic review. Human Reproduction Update 2010 16 6 704 712 2-s2.0-78649354212 10.1093/humupd/dmq017
5. le Ray C., Scherier S., Anselem O., Marszalek A., Tsatsaris V., Cabrol D., Goffinet F., Association between oocyte donation and maternal and perinatal outcomes in women aged 43 years or older. Human Reproduction 2012 27 3 896 901 2-s2.0-84857215502 10.1093/humrep/der469
6. van Nieuwenhoven A. L. V., Heineman M. J., Faas M. M., The immunology of successful pregnancy. Human Reproduction Update 2003 9 4 347 357 2-s2.0-0043025352 10.1093/humupd/dmg026 (Pubitemid 36987283)
7. Kanellopoulos-Langevin C., Caucheteux S. M., Verbeke P., Ojcius D. M., Tolerance of the fetus by the maternal immune system: role of inflammatory mediators at the feto-maternal interface. Reproductive Biology and Endocrinology 2003 1, article 121 2-s2.0-3042581643 10.1186/1477-7827-1-121 (Pubitemid 39130404)
8. Red-Horse K., Zhou Y., Genbacev O., Prakobphol A., Foulk R., McMaster M., Fisher S. J., Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. Journal of Clinical Investigation 2004 114 6 744 754 2-s2.0-9644254252 10.1172/JCI200422991 (Pubitemid 39578730)
9. Kliman H. J., Uteroplacental blood flow: the story of decidualization, menstruation, and trophoblast invasion. The American Journal of Pathology 2000 157 6 1759 1768 2-s2.0-0033638444
10. Mayhew T. M., Leach L., McGee R., Ismail W. W., Myklebust R., Lammiman M. J., Proliferation, differentiation and apoptosis in villous trophoblast at 13-41 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes). Placenta 1999 20 5-6 407 422 2-s2.0-0033168846 10.1053/plac.1999.0399 (Pubitemid 29301614)
11. Huppertz B., Frank H.-G., Kingdom J. C. P., Reister F., Kaufmann P., Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochemistry and Cell Biology 1998 110 5 495 508 2-s2.0-0031754353 10.1007/s004180050311 (Pubitemid 28480282)
12. Nelson D. M., Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta 1996 17 7 387 391 2-s2.0-0029838801 10.1016/S0143-4004(96)90019-3 (Pubitemid 26381675)
13. Huppertz B., Kingdom J., Caniggia I., Desoye G., Black S., Korr H., Kaufmann P., Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta 2003 24 2-3 181 190 2-s2.0-0038335391 10.1053/plac.2002.0903 (Pubitemid 37184714)
14. Sargent I. L., Germain S. J., Sacks G. P., Kumar S., Redman C. W. G., Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. Journal of Reproductive Immunology 2003 59 2 153 160 2-s2.0-0043170869 10.1016/S0165-0378(03)00044-5 (Pubitemid 36945233)
15. Gupta A. K., Hasler P., Holzgreve W., Gebhardt S., Hahn S., Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Human Immunology 2005 66 11 1146 1154 2-s2.0-33645234855 10.1016/j.humimm.2005.11.003
16. Gupta A. K., Holzgreve W., Hahn S., Decrease in lipid levels of syncytiotrophoblast micro-particles reduced their potential to inhibit endothelial cell proliferation. Archives of Gynecology and Obstetrics 2008 277 2 115 119 2-s2.0-37349103786 10.1007/s00404-007-0425-2 (Pubitemid 350308022)
17. Blois S. M., Klapp B. F., Barrientos G., Decidualization and angiogenesis in early pregnancy: unravelling the functions of DC and NK cells. Journal of Reproductive Immunology 2011 88 2 86 92 2-s2.0-79952694937 10.1016/j.jri.2010. 11.002
18. Chen S.-J., Liu Y.-L., Sytwu H.-K., Immunologic regulation in pregnancy: from mechanism to therapeutic strategy for immunomodulation. Clinical and Developmental Immunology 2012 2012 10 2-s2.0-84855171269 10.1155/2012/258391 258391
19. Zhang J., Chen Z., Smith G. N., Croy B. A., Natural killer cell-triggered vascular transformation: maternal care before birth? Cellular and Molecular Immunology 2011 8 1 1 11 2-s2.0-79952522230 10.1038/cmi.2010.38
20. Dekel N., Gnainsky Y., Granot I., Mor G., Inflammation and implantation. The American Journal of Reproductive Immunology 2010 63 1 17 21 2-s2.0-72549106478 10.1111/j.1600-0897.2009.00792.x
21. Hanna J., Goldman-Wohl D., Hamani Y., Avraham I., Greenfield C., Natanson-Yaron S., Prus D., Cohen-Daniel L., Arnon T. I., Manaster I., Gazit R., Yutkin V., Benharroch D., Porgador A., Keshet E., Yagel S., Mandelboim O., Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nature Medicine 2006 12 9 1065 1074 2-s2.0-33748440547 10.1038/nm1452 (Pubitemid 44353388)
22. Leonard S., Murrant C., Tayade C., van den Heuvel M., Watering R., Croy B. A., Mechanisms regulating immune cell contributions to spiral artery modification-facts and hypotheses-a review. Placenta 2006 27, supplement A 40 46 2-s2.0-33645989737 10.1016/j.placenta.2005.11.007
23. Kalkunte S., Chichester C. O., Gotsch F., Sentman C. L., Romero R., Sharma S., Evolution of non-cytotoxic uterine natural killer cells. The American Journal of Reproductive Immunology 2008 59 5 425 432 2-s2.0-42149183554 10.1111/j.1600-0897.2008.00595.x (Pubitemid 351524232)
24. Guleria I., Sayegh M. H., Maternal acceptance of the fetus: true human tolerance. Journal of Immunology 2007 178 6 3345 3351 2-s2.0-33947233249 (Pubitemid 46417596)
25. Hiby S. E., Walker J. J., O'Shaughnessy K. M., Redman C. W. G., Carrington M., Trowsdale J., Moffett A., Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. Journal of Experimental Medicine 2004 200 8 957 965 2-s2.0-7244234068 10.1084/jem.20041214 (Pubitemid 39431121)
26. Moffett A., Loke C., Immunology of placentation in eutherian mammals. Nature Reviews Immunology 2006 6 8 584 594 2-s2.0-33746517978 10.1038/nri1897 (Pubitemid 44134091)
27. Laresgoiti-Servitje E., Gómez-lópez N., Olson D. M., An immunological insight into the origins of pre-eclampsia. Human Reproduction Update 2010 16 5 510 524 2-s2.0-77955672760 10.1093/humupd/dmq007
28. Hiby S. E., Apps R., Sharkey A. M., Farrell L. E., Gardner L., Mulder A., Claas F. H., Walker J. J., Redman C. C., Morgan L., Tower C., Regan L., Moore G. E., Carrington M., Moffett A., Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. Journal of Clinical Investigation 2010 120 11 4102 4110 2-s2.0-78049433758 10.1172/JCI43998
29. Saito S., Sakai M., Sasaki Y., Nakashima A., Shiozaki A., Inadequate tolerance induction may induce pre-eclampsia. Journal of Reproductive Immunology 2007 76 1-2 30 39 2-s2.0-36048949571 10.1016/j.jri.2007.08.002 (Pubitemid 350100884)
30. Kleinrouweler C. E., Wiegerinck M. M. J., Ris-Stalpers C., Bossuyt P. M. M., van der Post J. A. M., von Dadelszen P., Mol B. W. J., Pajkrt E., Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. The British Journal of Obstetrics and Gynaecology 2012 119 7 778 787 2-s2.0-84861094112 10.1111/j.1471-0528.2012.03311.x
31. Sakai M., Ogawa K., Shiozaki A., Yoneda S., Sasaki Y., Nagata K., Saito S., Serum granulysin is a marker for Th1 type immunity in pre-eclampsia. Clinical and Experimental Immunology 2004 136 1 114 119 2-s2.0-1842559616 10.1111/j.1365-2249.2004.02414.x (Pubitemid 38437773)
32. Qiu C., Saito S., Sakai M., Ogawa K., Nagata K., Williams M. A., Plasma granulysin concentrations and preeclampsia risk. Clinical Biochemistry 2006 39 10 1016 1021 2-s2.0-33748967570 10.1016/j.clinbiochem.2006.07.008 (Pubitemid 44442163)
33. Molvarec A., Shiozaki A., Ito M., Toldi G., Stenczer B., Szarka A., Nakashima A., Vásárhelyi B., Rigó J. Jr., Saito S., Increased prevalence of peripheral blood granulysin-producing cytotoxic T lymphocytes in preeclampsia. Journal of Reproductive Immunology 2011 91 1-2 56 63 2-s2.0-80052397990 10.1016/j.jri.2011.03.012
34. Jonsson Y., Rubèr M., Matthiesen L., Berg G., Nieminen K., Sharma S., Ernerudh J., Ekerfelt C., Cytokine mapping of sera from women with preeclampsia and normal pregnancies. Journal of Reproductive Immunology 2006 70 1-2 83 91 2-s2.0-33646531177 10.1016/j.jri.2005.10.007
35. Negishi Y., Wakabayashi A., Shimizu M., Ichikawa T., Kumagai Y., Takeshita T., Takahashi H., Disruption of maternal immune balance maintained by innate DC subsets results in spontaneous pregnancy loss in mice. Immunobiology 2012 217 10 951 961 2-s2.0-84865389590 10.1016/j.imbio.2012.01.011
36. Lee J. Y., Lee M., Lee S. K., Role of endometrial immune cells in implantation. Clinical and Experimental Reproductive Medicine 2011 38 3 119 125
37. Schulke L., Manconi F., Markham R., Fraser I. S., Endometrial dendritic cell populations during the normal menstrual cycle. Human Reproduction 2008 23 7 1574 1580 2-s2.0-44949162947 10.1093/humrep/den030 (Pubitemid 351809694)
38. Kämmerer U., Eggert A. O., Kapp M., McLellan A. D., Geijtenbeek T. B. H., Dietl J., van Kooyk Y., Kämpgen E., Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. The American Journal of Pathology 2003 162 3 887 896 2-s2.0-0344643425 (Pubitemid 36237496)
39. Breburda E. E., Dambaeva S. V., Slukvin I. I., Golos T. G., Selective distribution and pregnancy-specific expression of DC-SIGN at the maternal-fetal interface in the rhesus macaque: DC-SIGN is a putative marker of the recognition of pregnancy. Placenta 2006 27 1 11 21 2-s2.0-27944486537 10.1016/j.placenta. 2004.11.006 (Pubitemid 41662875)
40. Plaks V., Birnberg T., Berkutzki T., Sela S., BenYashar A., Kalchenko V., Mor G., Keshet E., Dekel N., Neeman M., Jung S., Uterine DCs are crucial for decidua formation during embryo implantation in mice. Journal of Clinical Investigation 2008 118 12 3954 3965 2-s2.0-57449101121 10.1172/JCI36682
41. Kemp B., Schmitz S., Krusche C. A., Rath W., von Rango U., Dendritic cells are equally distributed in intrauterine and tubal ectopic pregnancies. Fertility and Sterility 2011 95 1 28 32 2-s2.0-78650417578 10.1016/j.fertnstert. 2010.05.045
42. Lee H.-M., Bautista J. L., Hsieh C.-S., Thymic and peripheral differentiation of regulatory T cells. Advances in Immunology 2011 112 25 71 2-s2.0-82155170631 10.1016/B978-0-12-387827-4.00002-4
43. Schumacher A., Wafula P. O., Teles A., El-Mousleh T., Linzke N., Zenclussen M. L., Langwisch S., Heinze K., Wollenberg I., Casalis P. A., Volk H.-D., Fest S., Zenclussen A. C., Blockage of heme oxygenase-1 abrogates the protective effect of regulatory T cells on murine pregnancy and promotes the maturation of dendritic cells. PLoS ONE 2012 7 8 2-s2.0-84865023491 10.1371/journal.pone.0042301 e42301
44. Linzke N., Schumacher A., Woidacki K., Croy B. A., Linzke N., Zenclussen A. C., Carbon monoxide promotes proliferation of uterine natural killer cells and remodeling of spiral arteries in pregnant hypertensive heme oxygenase-1 mutant mice. Hypertension 2014 63 3 580 588 2-s2.0-84874922437 10.1161/HYPERTENSIONAHA.113.02403
45. Zenclussen M. L., Casalis P. A., El-Mousleh T., Rebelo S., Langwisch S., Linzke N., Volk H.-D., Fest S., Soares M. P., Zenclussen A. C., Haem oxygenase-1 dictates intrauterine fetal survival in mice via carbon monoxide. Journal of Pathology 2011 225 2 293 304 2-s2.0-80052507321 10.1002/path.2946
46. George E. M., Hosick P. A., Stec D. E., Granger J. P., Heme oxygenase inhibition increases blood pressure in pregnant rats. The American Journal of Hypertension 2013 26 7 924 930 2-s2.0-84878854626 10.1093/ajh/hpt045
47. Gnainsky Y., Granot I., Aldo P. B., Barash A., Or Y., Schechtman E., Mor G., Dekel N., Local injury of the endometrium induces an inflammatory response that promotes successful implantation. Fertility and Sterility 2010 94 6 2030 2036 2-s2.0-78049281846 10.1016/j.fertnstert.2010.02.022
48. Guenther S., Vrekoussis T., Heublein S., Bayer B., Anz D., Knabl J., Navrozoglou I., Dian D., Friese K., Makrigiannakis A., Jeschke U., Decidual macrophages are significantly increased in spontaneous miscarriages and over-express FasL: a potential role for macrophages in trophoblast apoptosis. International Journal of Molecular Sciences 2012 13 7 9069 9080 2-s2.0-84864328742 10.3390/ijms13079069
49. Gustafsson C., Mjösberg J., Matussek A., Geffers R., Matthiesen L., Berg G., Sharma S., Buer J., Ernerudh J., Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS ONE 2008 3 4 2-s2.0-44349147785 10.1371/journal.pone.0002078 e2078 (Pubitemid 352025020)
50. Nagamatsu T., Schust D. J., The contribution of macrophages to normal and pathological pregnancies. The American Journal of Reproductive Immunology 2010 63 6 460 471 2-s2.0-77953946507 10.1111/j.1600-0897.2010.00813.x
51. Devaraj S., Jialal I., C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 6 1397 1402 2-s2.0-79957460693 10.1161/ATVBAHA.111.225508
52. Huang S. J., Zenclussen A. C., Chen C.-P., Basar M., Yang H., Arcuri F., Li M., Kocamaz E., Buchwalder L., Rahman M., Kayisli U., Schatz F., Toti P., Lockwood C. J., The implication of aberrant GM-CSF expression in decidual cells in the pathogenesis of preeclampsia. The American Journal of Pathology 2010 177 5 2472 2482 2-s2.0-78149291433 10.2353/ajpath.2010.091247
53. Hayashi M., Hamada Y., Ohkura T., Elevation of granulocyte-macrophage colony-stimulating factor in the placenta and blood in preeclampsia. The American Journal of Obstetrics and Gynecology 2004 190 2 456 461 2-s2.0-1342324164 10.1016/j.ajog.2003.07.032 (Pubitemid 38249244)
54. Agostinis C., Bossi F., Masat E., Radillo O., Tonon M., de Seta F., Tedesco F., Bulla R., MBL interferes with endovascular trophoblast invasion in pre-eclampsia. Clinical and Developmental Immunology 2012 2012 7 2-s2.0-84855579355 10.1155/2012/484321 484321
55. Denny K. J., Woodruff T. M., Taylor S. M., Callaway L. K., Complement in pregnancy: a delicate balance. The American Journal of Reproductive Immunology 2013 69 1 3 11 2-s2.0-84870734684 10.1111/aji.12000
56. Singh J., Ahmed A., Girardi G., Role of complement component C1q in the onset of preeclampsia in mice. Hypertension 2011 58 4 716 724 2-s2.0-80053562454 10.1161/HYPERTENSIONAHA.111.175919
57. Than N. G., Romero R., Erez O., Kusanovic J. P., Tarca A. L., Edwin S. S., Kim J.-S., Hassan S. S., Espinoza J., Mittal P., Mazaki-Tovi S., Friel L., Gotsch F., Vaisbuch E., Camacho N., Papp Z., A role for mannose-binding lectin, a component of the innate immune system in pre-eclampsia. The American Journal of Reproductive Immunology 2008 60 4 333 345 2-s2.0-51649111986 10.1111/j.1600-0897.2008.00631.x
58. Halmos A., Rigó J. Jr., Szijártó J., Füst G., Prohászka Z., Molvarec A., Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia. Clinical and Experimental Immunology 2012 169 1 49 56 10.1111/j.1365-2249.2012.04590.x
59. Derzsy Z., Prohászka Z., Rigó J. Jr., Füst G., Molvarec A., Activation of the complement system in normal pregnancy and preeclampsia. Molecular Immunology 2010 47 7-8 1500 1506 2-s2.0-77950628595 10.1016/j.molimm.2010.01.021
60. Lynch A. M., Murphy J. R., Gibbs R. S., Levine R. J., Giclas P. C., Salmon J. E., Holers V. M., The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia. The British Journal of Obstetrics and Gynaecology 2010 117 4 456 462 2-s2.0-76349083613 10.1111/j.1471-0528.2009. 02473.x
61. Lynch A. M., Murphy J. R., Byers T., Gibbs R. S., Neville M. C., Giclas P. C., Salmon J. E., Holers V. M., Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. The American Journal of Obstetrics and Gynecology 2008 198 4 385.e1 385.e9 2-s2.0-41349089497 10.1016/j.ajog.2007.10.793
62. Soto E., Romero R., Richani K., Espinoza J., Chaiworapongsa T., Nien J. K., Edwin S. S., Kim Y. M., Hong J. S., Goncalves L. F., Yeo L., Mazor M., Hassan S. S., Kusanovic J. P., Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products. Journal of Maternal-Fetal and Neonatal Medicine 2010 23 7 646 657 2-s2.0-77953630998 10.3109/14767050903301009
63. Lynch A. M., Gibbs R. S., Murphy J. R., Giclas P. C., Salmon J. E., Holers V. M., Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes. Obstetrics and Gynecology 2011 117 1 75 83 2-s2.0-78650768741 10.1097/AOG.0b013e3181fc3afa
64. Lim R., Lappas M., Decreased expression of complement 3a receptor (C3aR) in human placentas from severe preeclamptic pregnancies. European Journal of Obstetrics Gynecology and Reproductive Biology 2012 165 2 194 198 2-s2.0-84870295573 10.1016/j.ejogrb.2012.08.003
65. Wang W., Irani R. A., Zhang Y., Ramin S. M., Blackwell S. C., Tao L., Kellems R. E., Xia Y., Autoantibody-mediated complement c3a receptor activation contributes to the pathogenesis of preeclampsia. Hypertension 2012 60 3 712 721 2-s2.0-84865480216 10.1161/HYPERTENSIONAHA.112.191817
66. Abrahams V. M., Visintin I., Aldo P. B., Guller S., Romero R., Mor G., A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. Journal of Immunology 2005 175 12 8096 8104 2-s2.0-29144506920 (Pubitemid 41798372)
67. Bernardi F. C. B., Felisberto F., Vuolo F., Petronilho F., Souza D. R., Luciano T. F., de Souza C. T., Ritter C., Dal-Pizzol F., Oxidative damage, inflammation, and toll-like receptor 4 pathway are increased in preeclamptic patients: a case-control study. Oxidative Medicine and Cellular Longevity 2012 2012 6 2-s2.0-84864933785 10.1155/2012/636419 636419
68. Nitsche J. F., Jiang S.-W., Brost B. C., Maternal neutrophil toll-like receptor mRNA expression is down-regulated in preeclampsia. The American Journal of Reproductive Immunology 2011 66 3 242 248 2-s2.0-84864418335
69. Hess A. P., Hamilton A. E., Talbi S., Dosiou C., Nyegaard M., Nayak N., Genbecev-Krtolica O., Mavrogianis P., Ferrer K., Kruessel J., Fazleabas A. T., Fisher S. J., Giudice L. C., Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators. Biology of Reproduction 2007 76 1 102 117 2-s2.0-33845766092 10.1095/biolreprod.106.054791 (Pubitemid 46013453)
70. Popovici R. M., Betzler N. K., Krause M. S., Luo M., Jauckus J., Germeyer A., Bloethner S., Schlotterer A., Kumar R., Strowitzki T., von Wolff M., Gene expression profiling of human endometrial-trophoblast interaction in a coculture model. Endocrinology 2006 147 12 5662 5675 2-s2.0-33751532969 10.1210/en.2006-0916 (Pubitemid 44833483)
71. Saso J., Shields S.-K., Zuo Y., Chakraborty C., Role of Rho GTPases in human trophoblast migration induced by IGFBP1. Biology of Reproduction 2012 86 1 1 9 2-s2.0-84856898446 10.1095/biolreprod.111.094698
72. Abrahams V. M., Straszewski-Chavez S. L., Guller S., Mor G., First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Molecular Human Reproduction 2004 10 1 55 63 2-s2.0-1042268903 10.1093/molehr/gah006 (Pubitemid 38195966)
73. Frängsmyr L., Baranov V., Nagaeva O., Stendahl U., Kjellberg L., Mincheva-Nilsson L., Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Molecular Human Reproduction 2005 11 1 35 41 2-s2.0-14744288921 10.1093/molehr/gah129 (Pubitemid 40331001)
74. Salimi S., Moudi B., Farajian Mashhadi F., Tavilani H., Hashemi M., Zand H., Yaghmaei M., Association of functional polymorphisms in FAS and FAS Ligand genes promoter with pre-eclampsia. Journal of Obstetrics and Gynaecology Research 2014 40 5 1167 1173
75. Petroff M. G., Chen L., Phillips T. A., Azzola D., Sedlmayr P., Hunt J. S., B7 family molecules are favorably positioned at the human maternal-fetal interface. Biology of Reproduction 2003 68 5 1496 1504 2-s2.0-0242584894 10.1095/biolreprod.102.010058 (Pubitemid 36519751)
76. Jin L.-P., Zhou Y.-H., Wang M.-Y., Zhu X.-Y., Li D.-J., Blockade of CD80 and CD86 at the time of implantation inhibits maternal rejection to the allogeneic fetus in abortion-prone matings. Journal of Reproductive Immunology 2005 65 2 133 146 2-s2.0-16244394884 10.1016/j.jri.2004.08.009 (Pubitemid 40461931)
77. Toldi G., Vásárhelyi B., Biró E., Fügedi G., Rigó J. Jr., Molvarec A., B7 costimulation and intracellular indoleamine-2, 3-dioxygenase expression in peripheral blood of healthy pregnant and pre-eclamptic women. The American Journal of Reproductive Immunology 2013 69 3 264 271
78. Wegmann T. G., Lin H., Guilbert L., Mosmann T. R., Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunology Today 1993 14 7 353 356 2-s2.0-0027207375 (Pubitemid 23198169)
79. Saito S., Tsukaguchi N., Hasegawa T., Michimata T., Tsuda H., Narita N., Distribution of Th1, Th2, and Th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells. The American Journal of Reproductive Immunology 1999 42 4 240 245 2-s2.0-0032753890 (Pubitemid 29501974)
80. Krasnow J. S., Tollerud D. J., Naus G., DeLoia J. A., Endometrial Th2 cytokine expression throughout the menstrual cycle and early pregnancy. Human Reproduction 1996 11 8 1747 1754 2-s2.0-0029848946 (Pubitemid 26318920)
81. Kwak-Kim J. Y. H., Gilman-Sachs A., Kim C. E., T helper 1 and 2 immune responses in relationship to pregnancy, nonpregnancy, recurrent spontaneous abortions and infertility of repeated implantation failures. Chemical Immunology and Allergy 2005 88 64 79 2-s2.0-30744475709 10.1159/000087821 (Pubitemid 43094377)
82. Raghupathy R., Makhseed M., Azizieh F., Hassan N., Al-Azemi M., Al-Shamali E., Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cellular Immunology 1999 196 2 122 130 2-s2.0-0032702338 10.1006/cimm.1999.1532 (Pubitemid 29496461)
83. Fraccaroli L., Alfieri J., Leiros C. P., Ramhorst R., Immunomodulatory effects of chemokines during the early implantation window. Frontiers in Bioscience (Elite edition) 2009 1 1 288 298 2-s2.0-77952098851
84. Ramhorst R., Patel R., Corigliano A., Etchepareborda J. J., Fainboim L., Schust D., Induction of maternal tolerance to fetal alloantigens by RANTES production. The American Journal of Reproductive Immunology 2006 56 5-6 302 311 2-s2.0-33750543572 10.1111/j.1600-0897.2006.00430.x (Pubitemid 44669326)
85. Szarka A., Rigó J. Jr., Lázár L., Beko G., Molvarec A., Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunology 2010 11, article 59 2-s2.0-78649590865 10.1186/1471-2172-11-59
86. Sakai M., Tsuda H., Tanebe K., Sasaki Y., Saito S., Interleukin-12 secretion by peripheral blood mononuclear cells is decreased in normal pregnant subjects and increased in preeclamptic patients. The American Journal of Reproductive Immunology 2002 47 2 91 97 2-s2.0-0036094438 10.1034/j.1600-0897. 2002.1o020.x (Pubitemid 34552380)
87. + regulatory T cell compartment. Journal of Immunology 2004 173 4 2227 2230 2-s2.0-4043071317 (Pubitemid 39063075)
88. Tilburgs T., Scherjon S. A., van der Mast B. J., Haasnoot G. W., Versteeg-V D Voort-Maarschalk M., Roelen D. L., van Rood J. J., Claas F. H. J., Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. Journal of Reproductive Immunology 2009 82 2 148 157 2-s2.0-77953383314
89. + regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Molecular Human Reproduction 2004 10 5 347 353 2-s2.0-2642576534 10.1093/molehr/gah044 (Pubitemid 38714366)
90. Miwa N., Hayakawa S., Miyazaki S., Myojo S., Sasaki Y., Sakai M., Takikawa O., Saito S., IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon- γ increase in normal pregnancy but decrease in spontaneous abortion. Molecular Human Reproduction 2005 11 12 865 870 2-s2.0-33645090953 10.1093/molehr/gah246
91. + regulatory T-cell subset. Immunology 2004 112 1 38 43 2-s2.0-2342603958 10.1111/j.1365-2567.2004.01869.x (Pubitemid 38609820)
92. + Treg cells during midterm pregnancy in mice. Endocrinology 2010 151 11 5477 5488 2-s2.0-78049493627 10.1210/en.2010-0426
93. Wang W.-J., Hao C.-F., Qu Q.-L., Wang X., Qiu L.-H., Lin Q.-D., The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage. Human Reproduction 2010 25 10 2591 2596 2-s2.0-77956893681 10.1093/humrep/deq198
94. Wang W.-J., Hao C.-F., Yin G.-J., Bao S.-H., Qiu L.-H., Lin Q.-D., Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. Journal of Reproductive Immunology 2010 84 2 164 170 2-s2.0-76749131032 10.1016/j.jri.2009.12.003
95. Wu Z., You Z., Zhang C., Li Z., Su X., Zhang X., Li Y., Association between functional polymorphisms of FoxP3 gene and the occurrence of unexplained recurrent spontaneous abortion in a Chinese Han population. Clinical and Developmental Immunology 2012 2012 7 2-s2.0-80053473319 10.1155/2012/896458 896458
96. + CD25 bright regulatory T cells in pre-eclampsia. Clinical and Experimental Immunology 2007 149 1 139 145 2-s2.0-34250182084 10.1111/j.1365-2249.2007.03397.x (Pubitemid 46897107)
97. + regulatory T cells in normal pregnancy and pre-eclampsia. The American Journal of Reproductive Immunology 2012 68 2 175 180 2-s2.0-84863877451 10.1111/j.1600-0897.2012.01145.x
98. Toldi G., Rigó J. Jr., Stenczer B., Vásárhelyi B., Molvarec A., Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. The American Journal of Reproductive Immunology 2011 66 3 223 229
99. Gundogan F., Bianchi D. W., Scherjon S. A., Roberts D. J., Placental pathology in egg donor pregnancies. Fertility and Sterility 2010 93 2 397 404 2-s2.0-74449092126 10.1016/j.fertnstert.2008.12.144
100. Samstein R. M., Josefowicz S. Z., Arvey A., Treuting P. M., Rudensky A. Y., Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 2012 150 1 29 38 2-s2.0-84863619688 10.1016/j.cell.2012.05.031
101. Williams Z., Inducing tolerance to pregnancy. The New England Journal of Medicine 2012 367 12 1159 1161
102. Schumacher A., Wafula P. O., Bertoja A. Z., Sollwedel A., Thuere C., Wollenberg I., Yagita H., Volk H.-D., Zenclussen A. C., Mechanisms of action of regulatory T cells specific for paternal antigens during pregnancy. Obstetrics and Gynecology 2007 110 5 1137 1145 2-s2.0-35848936040 10.1097/01.AOG. 0000284625.10175.31 (Pubitemid 350059421)
103. + T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biology of Reproduction 2009 80 5 1036 1045 2-s2.0-65949108012 10.1095/biolreprod.108.074658
104. + cell pool and CCL19-mediated recruitment. Biology of Reproduction 2011 85 2 397 408 2-s2.0-79959990911 10.1095/biolreprod.110.088591
105. + cells facilitates embryo implantation. Frontiers in Immunology 2013 4 article 158 10.3389/fimmu.2013. 00158
106. Wang J. X., Knottnerus A.-M., Schuit G., Norman R. J., Chan A., Dekker G. A., Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia. The Lancet 2002 359 9307 673 674 2-s2.0-0037160761 10.1016/S0140-6736(02)07804-2 (Pubitemid 34203769)
107. Petroff M. G., Review: fetal antigens-Identity, origins, and influences on the maternal immune system. Placenta 2011 32 supplement 2 S176 S181 2-s2.0-79952006553 10.1016/j.placenta.2010.12.014
108. Muzzio D., Zenclussen A. C., Jensen F., The role of B cells in pregnancy: the good and the bad. The American Journal of Reproductive Immunology 2013 69 4 408 412 2-s2.0-84875054278 10.1111/aji.12079
109. + cells as indicators of preeclampsia. Hypertension 2012 59 4 861 868 2-s2.0-84858698215 10.1161/HYPERTENSIONAHA.111.188276
110. + B lymphocytes (B-1 cells) decrease in peripheral blood during pregnancy. Journal of Reproductive Immunology 1995 28 1 53 60 2-s2.0-0028819504
111. Chernyshov V. P., Tumanova L. E., Sudoma I. A., Bannikov V. I., Th1 and Th2 in human IVF pregnancy with allogenic fetus. The American Journal of Reproductive Immunology 2008 59 4 352 358 2-s2.0-40949148230 10.1111/j.1600-0897.2007.00578.x (Pubitemid 351404256)
112. Pecks U., Maass N., Neulen J., Oocyte donation: a risk factor for pregnancy-induced hypertension-a meta-analysis and case series. Deutsches Ärzteblatt International 2011 108 3 23 31 2-s2.0-79951937270 10.3238/arztebl.2011.0023
113. Klatsky P. C., Delaney S. S., Caughey A. B., Tran N. D., Schattman G. L., Rosenwaks Z., The role of embryonic origin in preeclampsia: a comparison of autologous in vitro fertilization and ovum donor pregnancies. Obstetrics and Gynecology 2010 116 6 1387 1392 2-s2.0-78650119341 10.1097/AOG.0b013e3181fb8e59
114. Lee J., Romero R., Xu Y., Kim J.-S., Topping V., Yoo W., Kusanovic J. P., Chaiworapongsa T., Hassan S. S., Yoon B. H., Kim C. J., A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLoS ONE 2011 6 2 2-s2.0-79951519837 10.1371/journal.pone.0016806 e16806